| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 5.32T | 5.38T | 5.35T | 4.34T | 4.13T | 3.80T |
| Gross Profit | 4.72T | 5.38T | 4.60T | 3.64T | 3.50T | 3.25T |
| EBITDA | 413.36B | 373.06B | 722.78B | 148.22B | 413.06B | 277.37B |
| Net Income | 139.34B | 243.13B | 529.65B | 26.41B | 224.84B | 142.48B |
Balance Sheet | ||||||
| Total Assets | 15.87T | 15.89T | 14.83T | 14.46T | 13.79T | 13.12T |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 1.03T | 1.23T | 1.25T | 1.17T | 1.07T |
| Total Debt | 688.00B | 691.20B | 1.29T | 904.07B | 1.02T | 992.99B |
| Total Liabilities | 11.52T | 11.66T | 11.96T | 11.43T | 11.75T | 11.09T |
| Stockholders Equity | 4.33T | 4.21T | 2.85T | 1.85T | 2.03T | 2.02T |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 547.65B | 601.59B | 356.86B | 578.52B | 601.66B |
| Operating Cash Flow | 0.00 | 573.01B | 634.29B | 381.00B | 600.02B | 626.20B |
| Investing Cash Flow | 0.00 | -272.24B | -640.09B | -257.38B | -358.31B | -373.72B |
| Financing Cash Flow | 0.00 | -481.66B | -112.62B | -92.36B | -170.11B | -94.50B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥5.60T | 7.65 | ― | 2.82% | 11.37% | 27.90% | |
74 Outperform | ¥14.44T | 13.03 | 20.81% | 3.33% | -2.10% | -8.76% | |
72 Outperform | ¥6.10T | 8.22 | 16.97% | 2.59% | 23.01% | 2.59% | |
72 Outperform | ¥1.73T | 17.60 | ― | 2.44% | -21.38% | 58.05% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | ¥5.29T | 7.36 | 10.61% | 3.26% | -8.02% | 5.21% | |
61 Neutral | ¥1.69T | 10.62 | 7.91% | 2.74% | -1.96% | 10.32% |